logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Christoph Zielinski

Central European Cooperative Oncology Group
H指数:82
被引数:3.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Final results of the phase II trial of HER-Vaxx, a B-cell peptide-based vaccine plus standard care of chemotherapy in patients with HER2-overexpressing advanced gastric cancer - (HERIZON)

HER-Vaxx II期临床试验的最终结果，该试验采用基于B细胞肽的疫苗联合化疗标准治疗方案，用于HER2过表达的晚期胃癌患者 - (HERIZON)

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Tobias, J.; Kundi, M.; Garner-Spitzer, E.; Zielinski, C. C.; Maglakelidze, M.; Andric, Z. G.; Petrovic, Z.; Nikolic, I. V.; Ryspayeva, D.; Bulat, I. V.; Nagarkar, R.; Chawla, T.; Chong, L. O.; Nixon, B.; Yavrom, S.; Ede, N. J.; Wiedermann, U.
Breakthrough Infections in SARS-CoV-2-Vaccinated Multiple Myeloma Patients Improve Cross-Protection against Omicron Variants

SARS-CoV-2-Vaccinated多发性骨髓瘤患者的突破性感染改善了针对Omicron变体的交叉保护

VACCINES
IF3.4
2024-05-093
OAAI
Wagner, Angelika; Garner-Spitzer, Erika; Auer, Claudia; Gattinger, Pia; Zwazl, Ines; Platzer, Rene; Orola-Taus, Maria; Pichler, Peter; Amman, Fabian; Bergthaler, Andreas; Huppa, Johannes B.; Stockinger, Hannes; Zielinski, Christoph C.; Valenta, Rudolf; Kundi, Michael; Wiedermann, Ursula
Lower pre-treatment B-cell gene expression signatures correspond with improved overall survival with palbociclib plus endocrine therapy in HR+/HER2-metastatic breast cancer: a biomarker analysis from the GEICAM/2013-02 PEARL trial
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Agrawal, Yash; Fernandez-Martinez, Aranzazu; Gil-Gil, Miguel; Zielinski, Christoph; Ruiz-Borrego, Manuel; Ciruelos, Eva; Munoz, Montserrat; Margeli, Mireia; Bermejo, Begona; Anton, Antonio; Kahan, Zsuzsanna; Csoszi, Tibor; Alonso-Romero, Jose L.; Garcia-Saenz, Jose Angel; Sanchez-Rovira, Pedro; Alvarez, Elena; Chacon, J. Ignacio; Gonzalez-Santiago, Santiago; Rodriguez, Cesar A.; Servitja, Sonia; Pfefferle, Adam D.; Herranz, Jesus; Liu, Yuan; Carey, Lisa A.; Romero-Camarero, Isabel; Caballero, Rosalia; Perou, Charles M.; Martin, Miguel
Body Mass Index and Treatment Efficacy in advanced Luminal Breast Cancer: Insights from the GEICAM/2013-02 (PEARL) trial
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Alva, Manuel; Lopez-Tarruella, Sara; Zielinski, Christoph; Ruiz-Borrego, Manuel; Turner, Nicholas; Ciruelos, Eva; Munoz, Montserrat; Bermejo, Begona; Margeli, Mireia; Anton, Antonio; Kahan, Zsuzsanna; Csoszi, Tibor; Casas, Maribel; Murillo, Laura; Murillo, Serafin Morales; Alba, Emilio; Yam, Einav Nili-Gal; Guerrero, Angel; Calvo, Lourdes; de la Haba-Rodriguez, Juan; Ramos, Manuel; Alvarez, Isabel; Garcia-Palomo, Andres; Koehler, Maria; Garcia-Saenz, Jose Angel; Chacon, J. Ignacio; Swift, Claire; Thallinger, Christiane; Gil-Gil, Miguel; Martin, Miguel
Frontline vaccination with the B-cell peptide compound HER-Vaxx (IMU-131), combined with standard-of-care chemotherapy induces high levels of HER2-specific antibodies mediating ADCC and intracellular phosphorylation inhibition resulting in overall survival benefit in patients with HER2+metastatic or advanced gastric/GEJ adenocarcinoma - Final results from Phase II/HERIZON study
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Tobias, Joshua; Kundi, Michael; Garner-Spitzer, Erika; Zielinski, Christoph; Maglakelidze, Marina; Andric, Zoran; Petrovic, Zoran; Nagarkar, Rajnish; Chawla, Tanuj; Chong, Leslie Mi Ok; Nixon, Bonnie; Yavrom, Sharon; Ede, Nicholas J.; Wiedermann, Ursula
Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
CLINICAL CANCER RESEARCH
IF10.2
2023-07-256
OAAI
Pascual, Javier; Gil-Gil, Miguel; Proszek, Paula; Zielinski, Christoph; Reay, Alistair; Ruiz-Borrego, Manuel; Cutts, Rosalind; Ciruelos Gil, Eva M.; Feber, Andrew; Munoz-Mateu, Montserrat; Swift, Claire; Bermejo, Begona; Herranz, Jesus; Margeli Vila, Mireia; Anton, Antonio; Kahan, Zsuzsanna; Csoeszi, Tibor; Liu, Yuan; Fernandez-Garcia, Daniel; Garcia-Murillas, Isaac; Hubank, Michael; Turner, Nicholas C.; Martin, Miguel
Tumor-agnostic efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: ROAR basket study
CANCER RESEARCH
IF16.6
2023-04-140
PRE
Subbiah, Vivek; Kreitman, Robert J.; Wainberg, Zev A.; Gazzah, Anas; Lassen, Ulrik; Stein, Alexander; Wen, Patrick Y.; Dietrich, Sascha; Jonge, Maja J. A.; Blay, Jean-Yves; Italiano, Antoine; Yonemori, Kan; Cho, Daniel C.; de Vos, Filip Y. F. L.; Moreau, Philippe; Fernandez, Elena Elez; Schellens, Jan H.; Zielinski, Christoph C.; Redhu, Suman; Passos, Vanessa Q.; Ilankumaran, Palanichamy; Bang, Yung-Jue
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial
NATURE MEDICINE
IF50
2023-04-1495
OAAI
Subbiah, Vivek; Kreitman, Robert J.; Wainberg, Zev A.; Gazzah, Anas; Lassen, Ulrik; Stein, Alexander; Wen, Patrick Y.; Dietrich, Sascha; de Jonge, Maja J. A.; Blay, Jean-Yves; Italiano, Antoine; Yonemori, Kan; Cho, Daniel C.; de Vos, Filip Y. F. L.; Moreau, Philippe; Fernandez, Elena Elez; Schellens, Jan H. M.; Zielinski, Christoph C.; Redhu, Suman; Boran, Aislyn; Passos, Vanessa Q.; Ilankumaran, Palanichamy; Bang, Yung-Jue
CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2-Metastatic Breast Cancer

CCNE1和PLK1介导HR /HER2-Metastatic乳腺癌对Palbociclib的耐药性

CLINICAL CANCER RESEARCH
IF10.2
2023-02-0716
OAAI
Guerrero-Zotano, Angel; Belli, Stefania; Zielinski, Christoph; Gil-Gil, Miguel; Fernandez-Serra, Antonio; Ruiz-Borrego, Manuel; Gil, Eva Maria Ciruelos; Pascual, Javier; Munoz-Mateu, Montserrat; Bermejo, Begon; Vila, Mireia Margeli; Anton, Antonio; Murillo, Laura; Nissenbaum, Bella; Liu, Yuan; Herranz, Jesus; Fernandez-Garcia, Daniel; Caballero, Rosalia; Lopez-Guerrero, Jose Antonio; Bianco, Roberto; Formisano, Luigi; Turner, Nicholas; Martin, Miguel

研究方向

暂未获取到该数据
M
Matthias Preusser
H 指数:96论文数:1,143被引数:4.4万
R
Rupert Bartsch
H 指数:53论文数:635被引数:1.1万
G
Gerald W. Prager
H 指数:44论文数:395被引数:6,791
I
Ingrid Pabinger
H 指数:88论文数:1,261被引数:3.2万
C
Cihan Ay
H 指数:68论文数:617被引数:2.0万
A
Anna S. Berghoff
H 指数:58论文数:849被引数:1.4万
Z
Zsuzsanna Kahán
H 指数:31论文数:264被引数:6,107
T
Thomas Brodowicz
H 指数:37论文数:231被引数:1.0万
U
Ursula Wiedermann
H 指数:45论文数:328被引数:6,590
M
Michael Kundi
H 指数:78论文数:697被引数:2.4万